A Study to Describe a Group of Spanish Patients With FMF and to Identify Suboptimally Treated Patients With Minimal Disease Activity and Its Impact on Quality of Life
Clinical trial NCT06923124 · COMPLETED
Trial details
- NCT number
- NCT06923124
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-03-30
- Primary completion
- 2024-05-28
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.